维普期刊资源整合服务平台（V6.5）

152篇 您的检索式：作者名="Rini B"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Sunitinib in patients with metastatic renal cell carcinoma显示文摘	MOTZER R J RINI B I BUKOWSKI R M	2006	JAMA2006，295，21：	1
2	Comparative ef-fectiveness of axitinib versus sorafenib in advanced renal cell car-cinoma( AXIS) : a randomised phase 3 trial显示文摘	RINI BI ESCUDIER B TOMCZAK P	2011	Lancet2011，378，9807：	1
3	Axitinib versus sorafenib as second - line therapy for metastatic renal cell carcinoma (mRCC) :results of phase Ⅲ AXIS trial 显示文摘	Rini BI Escudier B Tomczak P	2011	In ASCO Meeting Abstracts2011，，：	1
4	SU11248 and AG013736:current data and future trials in renal cell carcinoma显示文摘	RINI B I	2005	Clin Genitourin Cancer2005，4，3：	1
5	A phase Ⅱ trial of weekly intravenous gemcitabinc and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma显示文摘	George C M Vogelzang N J Rini B I	2002	Ann Oncol2002，13，1：	1
6	Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients withmetastatic renal cell carcinoma 显示文摘	RINI B I STEIN M SHANNON P	2011	Cancer2011，117，4：	1
7	Sunitinib reverses type-1 immune suppression and decreases T-regulatory ceils in renal cell carcinoma patients 显示文摘	Finke JH Rini B Ireland J	2008	Clin Cancer Res2008，14，20：	1
8	Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients显示文摘	Ko J S Zea A H Rini B I	2009	Clin Cancer Res2009，15，6：	1
9	Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma ( AX- IS) : a randomised phase 3 trial 显示文摘	Rini BI Escudier B Tomczak P	2011	Lancet2011，378，9807：	1
10	Cancer and Leukemia Group B 90206:a randomized phase Ⅲ trial of interferon-alpha or interferon alpha plus anti-vascular endothelial growth factor antibody(bevacizumab) in metastatic renal cell carcinoma显示文摘	Halabi S Taylor J	2004	Clin Cancer Res2004，10，8：	1
11	Recent progress in the management of advanced renal cell carcinoma 显示文摘	Garcia J A Rini B I	2007	CA Cancer J Clin2007，57，2：	1
12	Sunitinib mediates reversal of myeioid-derived suppressor cell accumulation in renal cell carcinoma patients显示文摘	KO J S ZEA A H RINI B I	2009	Clin Cancer Res2009，15，6：	1
13	Renal cell carcinoma 显示文摘	Rini BI Campbell SC Escudier B	2009	Lancet2009，373，9669：	1
14	A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B pro- tocolg0008显示文摘	Stadler W M Halabi S Rini B	2006	Cancer2006，107，6：	1
15	Axitinib with or without dose titration for first - line metastatic reanl cell carcinoma: a randomized double - blind phase 2 trial 显示文摘	Rini B Mellichar B Veda T	2013	Lancet Oncol2013，14，：	1
16	Renal cell carcinoma显示文摘	Rini BI Campbell SC Escudier B	2009	Lancet2009，373，9669：	1
17	Comparative effec- tiveness of axitinib versus sorafenib in advanced renal cell carci- noma (AXIS): a randomised phase 3 trial 显示文摘	RINI BI ESCUDIER B TOMCZAK P	2011	Lancet2011，378，9807：	1
18	Molecularly targeted therapy in renal cell carcinoma显示文摘	Rathmell W K Wright T M Rini B I	2005	Expert Rev Anticancer Ther2005，5，6：	1
19	Statins, fracture risk,and boneremodeling: what is true? 显示文摘	RIZZO M RINI G B	2006	The American journal of themedical sciences2006，332，2：	1
20	et aL Axitinib versus sorafenib as second-line therapy for metastatic renal cell calinoma (mRCC): results of phase 11I AXIS trial 显示文摘	Rini BI Escudier B Tomezak P	2011	J Clin Oncol2011，，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示